Context Therapeutics Inc. (NASDAQ: CNTX) Stock Information | RedChip

Context Therapeutics Inc. (NASDAQ: CNTX)


$1.1000
+0.1200 ( +8.91% ) 128.1K

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Market Data


Open


$1.1000

Previous close


$0.9800

Volume


128.1K

Market cap


$75.14M

Day range


$0.9720 - $1.2140

52 week range


$0.8900 - $2.7500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Dec 23, 2024
8-k 8K-related 60 Dec 02, 2024
10-q Quarterly Reports 55 Nov 06, 2024
8-k 8K-related 60 Sep 23, 2024
8-k 8K-related 15 Sep 17, 2024
4 Insider transactions 1 Sep 05, 2024
3 Insider transactions 2 Sep 05, 2024
4 Insider transactions 1 Sep 05, 2024
3 Insider transactions 2 Sep 05, 2024
8-k 8K-related 15 Sep 04, 2024

Latest News